![](https://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Zydus receives Mexican regulatory approval for cancer drug - Bhava
Zydus Lifesciencesannounced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava™, a Bevacizumab biosimilar. Bhava™ (Bevacizumab), will be marketed in …